–
Boundless Bio, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY21:
FY22:
–
FY23:
−46.9
FY24:
−60.8
FY25:
−46.7
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−38.3
FY24:
−26.1
FY25:
37.8
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
97.9
FY24:
89.8
FY25:
0.14
millions USD
FY21:
–
FY22:
–
FY23:
12.8
FY24:
2.88
FY25:
−8.72
(positive)
Change from FY21 to FY25
millions USD
FY21:
−25.3
FY22:
−40.7
FY23:
−47.5
FY24:
−63.4
FY25:
−47.2
All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.